poisar

Stocks · News reference

GE HealthCare Expands Global Research Collaborations for Photonova Spectra Photon-Counting CT

Fiscal.ai

GE HealthCare has announced an expansion of its global clinical and research collaborations to advance its next-generation photon-counting CT system, Photonova Spectra.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolThe Motley Fool Team

    GE HealthCare: 3 Key Takeaways for Long-Term Investors

    GE HealthCare raised its full-year 2026 organic revenue guidance to 4% and reported 6.2% organic revenue growth in Q3 2026. The company's equipment backlog grew 12% year-over-year to $23.7 billion. Key strengths include recurring revenue from its Pharmaceutical Diagnostics division, operational improvements through the Heartbeat operating system, and multiyear supply agreements for memory chips that provide manufacturing resilience amid industry shortages.